ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts

Mohan S, Thompson GR, Amaar YG, Hathaway G, Tschesche H, Baylink DJ (2002)
BIOCHEMISTRY 41(51): 15394-15403.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Mohan, S; Thompson, GR; Amaar, YG; Hathaway, G; Tschesche, HaraldUniBi; Baylink, DJ
Abstract / Bemerkung
IGF binding protein-5 (BP-5) is an important bone formation regulator. Therefore, elucidation of the identity of IGF binding protein-5 (BP-5) protease produced by osteoblasts is important for our understanding of the molecular pathways that control the action of BP-5. In this regard, BP-5 protease purified by various chromatographic steps from a conditioned medium of U2 human osteosarcoma cells migrated as a single major band, which comigrated with the protease activity in native PAGE and yielded multiple bands in SDS-PAGE under reducing conditions. N-Terminal sequencing of these bands revealed that three of the bands yielded amino acid sequences that were identical to that of alpha2 macroglobulin (alpha2M). Although alpha2M was produced by human osteoblasts (OBs), it was not found to be a BP-5 protease. Because alpha2M had been shown to complex with ADAM proteases and because ADAM-12 was found to cleave BP-3 and BP-5, we evaluated if one of the members of ADAM family was the BP-5 protease. On the basis of the findings that (1) purified preparations of BP-5 protease from U2 cell CM contained ADAM-9, (2) ADAM-9 is produced and secreted in high abundance by various human OB cell types, (3) purified ADAM-9 cleaved BP-5 effectively while it did not cleave other IGFBPs or did so with less potency, and (4) purified ADAM-9 bound to alpha2M, we conclude that ADAM-9 is a BP-5 protease produced by human OBs.
Erscheinungsjahr
2002
Zeitschriftentitel
BIOCHEMISTRY
Band
41
Ausgabe
51
Seite(n)
15394-15403
ISSN
0006-2960
eISSN
1520-4995
Page URI
https://pub.uni-bielefeld.de/record/1612891

Zitieren

Mohan S, Thompson GR, Amaar YG, Hathaway G, Tschesche H, Baylink DJ. ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. BIOCHEMISTRY. 2002;41(51):15394-15403.
Mohan, S., Thompson, G. R., Amaar, Y. G., Hathaway, G., Tschesche, H., & Baylink, D. J. (2002). ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. BIOCHEMISTRY, 41(51), 15394-15403. https://doi.org/10.1021/bi026458q
Mohan, S, Thompson, GR, Amaar, YG, Hathaway, G, Tschesche, Harald, and Baylink, DJ. 2002. “ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts”. BIOCHEMISTRY 41 (51): 15394-15403.
Mohan, S., Thompson, G. R., Amaar, Y. G., Hathaway, G., Tschesche, H., and Baylink, D. J. (2002). ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. BIOCHEMISTRY 41, 15394-15403.
Mohan, S., et al., 2002. ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. BIOCHEMISTRY, 41(51), p 15394-15403.
S. Mohan, et al., “ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts”, BIOCHEMISTRY, vol. 41, 2002, pp. 15394-15403.
Mohan, S., Thompson, G.R., Amaar, Y.G., Hathaway, G., Tschesche, H., Baylink, D.J.: ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. BIOCHEMISTRY. 41, 15394-15403 (2002).
Mohan, S, Thompson, GR, Amaar, YG, Hathaway, G, Tschesche, Harald, and Baylink, DJ. “ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts”. BIOCHEMISTRY 41.51 (2002): 15394-15403.

33 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Insulin- like Growth Factor-Binding Protein Action in Bone Tissue: A Key Role for Pregnancy- Associated Plasma Protein-A.
Beattie J, Al-Khafaji H, Noer PR, Alkharobi HE, Alhodhodi A, Meade J, El-Gendy R, Oxvig C., Front Endocrinol (Lausanne) 9(), 2018
PMID: 29503631
Role of IGF1 and EFN-EPH signaling in skeletal metabolism.
Lindsey RC, Rundle CH, Mohan S., J Mol Endocrinol 61(1), 2018
PMID: 29581239
Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
Araya HF, Sepulveda H, Lizama CO, Vega OA, Jerez S, Briceño PF, Thaler R, Riester SM, Antonelli M, Salazar-Onfray F, Rodríguez JP, Moreno RD, Montecino M, Charbonneau M, Dubois CM, Stein GS, van Wijnen AJ, Galindo MA., J Cell Biochem 119(10), 2018
PMID: 29923217
ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets.
Dreymueller D, Uhlig S, Ludwig A., Am J Physiol Lung Cell Mol Physiol 308(4), 2015
PMID: 25480335
Function of matrix IGF-1 in coupling bone resorption and formation.
Crane JL, Cao X., J Mol Med (Berl) 92(2), 2014
PMID: 24068256
ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury.
Roychaudhuri R, Hergrueter AH, Polverino F, Laucho-Contreras ME, Gupta K, Borregaard N, Owen CA., J Immunol 193(5), 2014
PMID: 25063875
Effects of mutated pregnancy-associated plasma protein-a on atherosclerotic lesion development in mice.
Boldt HB, Bale LK, Resch ZT, Oxvig C, Overgaard MT, Conover CA., Endocrinology 154(1), 2013
PMID: 23161866
The role of ADAM-mediated shedding in vascular biology.
Dreymueller D, Pruessmeyer J, Groth E, Ludwig A., Eur J Cell Biol 91(6-7), 2012
PMID: 22138087
Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy.
Josson S, Anderson CS, Sung SY, Johnstone PA, Kubo H, Hsieh CL, Arnold R, Gururajan M, Yates C, Chung LW., Prostate 71(3), 2011
PMID: 20672324
IGFBP-5 Metabolism Is Disrupted in the Rat Medial Meniscal Tear Model of Osteoarthritis.
Yates MP, Settle SL, Yocum SA, Aggarwal P, Vickery LE, Aguiar DJ, Skepner AP, Kellner D, Weinrich SL, Sverdrup FM., Cartilage 1(1), 2010
PMID: 26069535
Complement 1s is the serine protease that cleaves IGFBP-5 in human osteoarthritic joint fluid.
Busby WH, Yocum SA, Rowland M, Kellner D, Lazerwith S, Sverdrup F, Yates M, Radabaugh M, Clemmons DR., Osteoarthritis Cartilage 17(4), 2009
PMID: 18930415
IGF-IR in neuroprotection and brain tumors.
Gualco E, Wang JY, Del Valle L, Urbanska K, Peruzzi F, Khalili K, Amini S, Reiss K., Front Biosci (Landmark Ed) 14(), 2009
PMID: 19273072
ADAM8: a new therapeutic target for asthma.
Knolle MD, Owen CA., Expert Opin Ther Targets 13(5), 2009
PMID: 19397475
Insulin-like growth factor-binding proteins and bone metabolism.
Conover CA., Am J Physiol Endocrinol Metab 294(1), 2008
PMID: 18003717
Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.
Owen CA., Int J Chron Obstruct Pulmon Dis 3(2), 2008
PMID: 18686734
Cellular roles of ADAM12 in health and disease.
Kveiborg M, Albrechtsen R, Couchman JR, Wewer UM., Int J Biochem Cell Biol 40(9), 2008
PMID: 18342566
Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer.
Akkiprik M, Feng Y, Wang H, Chen K, Hu L, Sahin A, Krishnamurthy S, Ozer A, Hao X, Zhang W., Breast Cancer Res 10(4), 2008
PMID: 18710598
Insulin-like growth factor binding protein-5 in osteogenesis: facilitator or inhibitor?
Mukherjee A, Rotwein P., Growth Horm IGF Res 17(3), 2007
PMID: 17317255
Expression of ADAM9 (meltrin-gamma) around aseptically loosened total hip replacement implants.
Ma GF, Liljeström M, Ainola M, Chen T, Tiainen VM, Lappalainen R, Konttinen YT, Salo J., Rheumatology (Oxford) 45(7), 2006
PMID: 16418197
Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.
Beattie J, Allan GJ, Lochrie JD, Flint DJ., Biochem J 395(1), 2006
PMID: 16526944
The multi-functional role of insulin-like growth factor binding proteins in bone.
Govoni KE, Baylink DJ, Mohan S., Pediatr Nephrol 20(3), 2005
PMID: 15549410
ADAM proteases, ErbB pathways and cancer.
Zhou BB, Fridman JS, Liu X, Friedman SM, Newton RC, Scherle PA., Expert Opin Investig Drugs 14(6), 2005
PMID: 16004590
ADAM proteins in the brain.
Novak U., J Clin Neurosci 11(3), 2004
PMID: 14975408
Organogenesis of the exocrine gland.
Wang J, Laurie GW., Dev Biol 273(1), 2004
PMID: 15302594

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 12484779
PubMed | Europe PMC

Suchen in

Google Scholar